These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21269058)

  • 21. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
    Xi GL; Cheng JW; Lu GC
    Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
    Masuda S; Tamura K; Wakui H; Kanaoka T; Ohsawa M; Maeda A; Dejima T; Yanagi M; Azuma K; Umemura S
    Hypertens Res; 2009 Nov; 32(11):950-5. PubMed ID: 19713965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
    Hinoi T; Tomohiro Y; Kajiwara S; Matsuo S; Fujimoto Y; Yamamoto S; Shichijo T; Ono T
    Hypertens Res; 2008 Apr; 31(4):615-22. PubMed ID: 18633172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
    Younis F; Oron Y; Limor R; Stern N; Rosenthal T
    Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
    Nakayama S; Watada H; Mita T; Ikeda F; Shimizu T; Uchino H; Fujitani Y; Hirose T; Kawamori R
    Hypertens Res; 2008 Jan; 31(1):7-13. PubMed ID: 18360012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
    Yamagishi S; Takenaka K; Inoue H
    Med Hypotheses; 2006; 66(1):118-20. PubMed ID: 16154710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.
    Ichikawa Y
    Intern Med; 2007; 46(17):1331-6. PubMed ID: 17827829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients.
    Takagi H; Umemoto T;
    J Am Soc Hypertens; 2014 Aug; 8(8):578-92. PubMed ID: 25151319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
    Derosa G; Ragonesi PD; Mugellini A; Ciccarelli L; Fogari R
    Hypertens Res; 2004 Jul; 27(7):457-64. PubMed ID: 15302981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients.
    Yano Y; Hoshide S; Ishikawa J; Noguchi C; Tukui D; Takanori H; Tada M; Kanemaru Y; Yano A; Ishikawa S; Shimada K; Kario K
    Am J Hypertens; 2007 May; 20(5):565-72. PubMed ID: 17485023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
    Negro R; Hassan H
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
    Chujo D; Yagi K; Asano A; Muramoto H; Sakai S; Ohnishi A; Shintaku-Kubota M; Mabuchi H; Yamagishi M; Kobayashi J
    Hypertens Res; 2007 Dec; 30(12):1205-10. PubMed ID: 18344626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
    White WB; Littlejohn TW; Majul CR; Oigman W; Olvera R; Seeber M; Schumacher H; Mancia G
    Blood Press Monit; 2010 Aug; 15(4):205-12. PubMed ID: 20613496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.